Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: The RTOG RPA intra-classes analysis.

References

• Bezjak A, Adam J, Barton R, Panzarella T, Laperriere N, Wong CS, et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002; 38: 487–496
   PubMed Web of Science ®Google Scholar
• Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999; 43: 795–803
   PubMed Web of Science ®Google Scholar
• Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, et al. A multiinstitutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002; 53: 519–526
   PubMed Web of Science ®Google Scholar
• Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94: 2698–2705
   PubMed Web of Science ®Google Scholar
• Berqvist M, Brattstrom D, Bennmarker H, Wagenius G, Riska H, Brodin O. Irradiation of brain metastases from lung cancer: A retrospective study. Lung Cancer 1998; 20: 57–63
   PubMedGoogle Scholar
• Penel N, Brichet A, Prevost B, Duhamel A, Assaker R, Dubois F, et al. Prognostic factors of synchronous brain metastases. Lung Cancer 2001; 33: 143–154
   PubMedGoogle Scholar
• Rodrigus P, de Brouwer P, Raaymakers E. Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation. Lung Cancer 2001; 32: 129–136
   PubMed Web of Science ®Google Scholar
• Ryan GF, Ball DL, Smith JG. Treatment of brain metastases from primary lung cancer. Int J Radiat Oncol Biol Phys 1995; 31: 273–278
   PubMedGoogle Scholar
• Sen M, Demiral AS, Cetingoz R, Alanyali H, Akman F, Senturk D, et al. Prognostic factors in lung cancer with brain metastasis. Radiother Oncol 1998; 46: 33–38
   PubMedGoogle Scholar
• Hoffman R, Sneed PK, McDermott MW, Chang S, Lamborn KR, Park E, et al. Radiosurgery for brain metastases from primary lung carcinoma. Cancer J 2001; 7: 121–131
   PubMedGoogle Scholar
• Noordijk EM, Vecht JC, Haaxma-Reiche H, Padberg W. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994; 29: 711–717
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Walsh JH, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322: 494–500
   PubMed Web of Science ®Google Scholar
• Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 2002; 97: 1276–1281
   PubMed Web of Science ®Google Scholar
• Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 1665–1672
   PubMed Web of Science ®Google Scholar
• Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745–751
   PubMed Web of Science ®Google Scholar
• Gaspar LE, Scott C, Murray K, Curran W, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000; 47: 1001–1006
   PubMed Web of Science ®Google Scholar
• Lutterbach J, Bartelt S, Stancu E, Guttenberger R. Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3. Radiother Oncol 2002; 63: 339–345
   PubMed Web of Science ®Google Scholar
• Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel M, et al. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?. Int J Radiat Oncol Biol Phys 2000; 46: 297–302
   PubMed Web of Science ®Google Scholar
• Weltman E, Salvajoli JV, Brandt RA, Hanriot RM, Prisco FE, Cruz JC, et al. Radiosurgery for brain metastases: who may not benefit?. Int J Radiat Oncol Biol Phys 2001; 51: 1320–1327
   PubMedGoogle Scholar
• Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP, et al. Fundamental dilemmas of the randomized clinical trial process: Results of a survey of the 1,737 Eastern Cooperative Oncology Group Investigators. J Clin Oncol 1994; 12: 1796–1805
   PubMed Web of Science ®Google Scholar
• Postmus PE, Haaxma-Reiche H, Gregor A, Groen HJ, Lewinski T, Scolard T, et al. Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 1998; 46: 29–32
   PubMedGoogle Scholar
• Noterman J, Hildebrand J, Rocmans P. Long term survival after surgery of solitary cerebral metastasis of lung cancer: clinical case and review of the literature. Neurochirurgie 1990; 36: 308–311
   PubMedGoogle Scholar
• Diener-West M, Dobbins TW, Phillips TL, Nelson DF, et al. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 1989; 16: 669–673
   PubMedGoogle Scholar
• Elliot JA, Osterlind K, Hirsch FR, Hansen HH, et al. Metastatic pattern in small cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients. J Clin Oncol 1987; 5: 246–254
   PubMedGoogle Scholar
• Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20561 cases. Ann Oncol 2002; 13: 1087–93
   PubMed Web of Science ®Google Scholar
• Epstein BE, Scott CB, Sause WT, Rotman M, Sneed PK, Janjan NA, et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 Gy and greater. Results of Radiation Therapy Oncology Group 85–28. Cancer 1993; 71: 1362–1367
   PubMed Web of Science ®Google Scholar